Untitled 3

Source R&D is the authoritative source of technology and services information supporting pharmaceutical and biotechnology companies in their drug discovery and development research projects.

Source R&D features extensive listings of service providers classified under company or organisation type, including contract chemical manufacturers; contract biologics manufacturers; biological research companies and organisations; and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

The extensive coverage of Source R&D and the support of life sciences organisations One Nucleus and Bionow make it an invaluable reference tool that streamlines the vendor selection process to bring pharmaceutical/biotechnology companies and suppliers together.

JXTG Energy sells Irvine Scientific to FujiFilm

JXTG Nippon Oil & Energy Corporation is to sell Irvine Scientific Sales Company, Inc and IS Japan Co, Ltd to FUJIFILM Corporation. JXTG Energy acquired Irvine Scientific in 1987 and launched IS Japan in 1989: both companies have continuously expanded to…
  • Published in Source R&D
  • Read: 271 times

Gyros Protein Technologies introduces Gyrolab xPand to improve immunoassay workflow in biotherapeutic discovery, development and production

Gyros Protein Technologies has introduced its Gyrolab® xPand immunoassay platform to provide higher throughput, greater flexibility and faster analysis of large sample numbers in biotherapeutic development. The new platform features more advanced instrumentation and software that are designed to ensure 21 CFR…
  • Published in Source R&D
  • Read: 254 times

BIA Separations and RBPS Technology partner on large-scale DNA vector production

Slovenia-headquartered biochromatography development and manufacturing company BIA Separations and RBPS Technology, the developer of the proprietary Minicircle DNA technology, have formed a partnership to provide scalable manufacture of Minicircle DNA at high purity. The project combines BIA Separations’ monolithic purification…
  • Published in Source R&D
  • Read: 249 times

Metrion Biosciences establishes Scientific Advisory Board

Ion channel contract research and drug discovery specialist Metrion Biosciences has established a scientific advisory board (SAB) to provide strategic scientific guidance to the company. The SAB members were selected for their extensive and diverse experience in ion channel screening,…
  • Published in Source R&D
  • Read: 343 times

Concept Life Sciences completes phase 1 of GXP plan

Drug discovery, development and analytical services company Concept Life Sciences has completed the first phase of its GXP compliance plan, achieving GLP (good laboratory practice) accreditation of its Dundee, UK site last December for in-vitro safety studies and bioanalysis. The accreditation increases…
  • Published in Source R&D
  • Read: 331 times

Enamine and BioSolveIT launch large-scale chemical compound sourcing database

Chemical research organisation Enamine Ltd and medicinal chemistry software specialist BioSolveIT GmbH have launched their jointly-developed REAL Space Navigator software tool which provides efficient search-and-find access to more than 640 million pharmaceutical-oriented molecules, to date the world's largest chemical space…
  • Published in Source R&D
  • Read: 259 times

Quotient Siences signs cocrystal formulations evaluation agreement with Nuformix

Quotient Siences has established an agreement with Nuformix Technologies to evaluate the clinical performance of Nuformix’s lead pharmaceutical cocrystal, NXP001, which is based on a currently marketed treatment in the field of oncology supportive care. Pharmaceutical cocrystals, re-engineered crystalline forms of…
  • Published in Source R&D
  • Read: 302 times

Irvine Scientific increases cell culture dry powder media production capacity

Cell culture media specialist Irvine Scientific has exanded its dry powder cell culture media manufacturing facility in Santa Ana, California to increase overall production capacity, including large-scale cGMP manufacturing. The multi-step expansion included more space dedicated to animal component free…
  • Published in Source R&D
  • Read: 313 times

Horizon Discovery launches genome-wide CRISPR screening services

Gene editing and gene modulation technologies specialist Horizon Discovery has expanded its functional genomic screening portfolio to include CRISPRi (interference) and CRISPRa (activation) screening services. Although functional genomic screening using CRISPR gene-knockout technology has provided a powerful and precise way to identify…
  • Published in Source R&D
  • Read: 330 times

Glythera and IONTAS in antibody-drug conjugate licence agreement

Antibody-drug conjugate developer Glythera Limited, and IONTAS Limited, a provider of services and platform technologies associated with the discovery and optimisation of fully-human antibody drugs, have established a collaborative agreement for the development of ADCs for difficult-to-treat cancers. IONTAS will…
  • Published in Source R&D
  • Read: 374 times

Avacta Group plc establishes US business development team

Biotherapeutics and bioreagents specialist Avacta Group plc has established a three-person commercial team in the US including Dr Matthew Vincent as Vice President Therapeutics Business Development. The new team has been established in order to exploit the rapidly growing interest…
  • Published in Source R&D
  • Read: 333 times

UK launch for Seqirus adjuvanted influenza vaccine

Seqirus, a global vaccine company specialising in influenza products, has launched FLUAD vaccine in the UK to help meet the significant health need in the country’s elderly population and to contribute to reducing the burden of influenza in national, regional…
  • Published in Source R&D
  • Read: 453 times

BioreclamationIVT acquires Qualyst Transporter Solutions

BioreclamationIVT, a provider of biospecimens and related services, today has acquired Qualyst Transporter Solutions, LLC, a company that provides in-vitro hepatic models and services that predict the effect on the human liver of drugs and other compounds used in the…
  • Published in Source R&D
  • Read: 470 times
Subscribe to this RSS feed